Health Education England (HEE) are seeking the views of frontline community pharmacists to support the development of further training modules that support pharmacists in the provision of NHS community pharmacy services across England. HEE are working closely with NHS England and NHS Improvement to provide these training opportunities. Since 2019, the Centre for Pharmacy Postgraduate Education and the Royal Pharmaceutical
Read moreThe recently appointed Chief Pharmaceutical Officer (CPhO) for England, David Webb, delivered a keynote speech in person at the National Meeting of LPCs and PSNC on Thursday 17th May 2022. As the new head of the pharmacy professions, he set out his personal priorities for the next few years. At the start of his speech,
Read morePSNC has submitted its response to the proposals set out in the Department of Health and Social Care’s (DHSC’s) consultation on hub and spoke dispensing. The consultation proposes making legislative changes to allow the operation of hub and spoke dispensing across different legal entities, and proposes to introduce two different models for this. Model 1
Read moreAs part of recovery plans following COVID-19, the Royal College of General Practitioners (RCGP) has produced guidance for clinicians working in general practice, which sets out suggested actions for consideration to support long-term condition management over the next six months. Among the suggestions is for clinicians to consider signposting patients with cardiovascular disease to the
Read moreIn response to a significant ongoing disruption to the supply affecting Lipitor® 10mg chewable tablets and Paracetamol 120mg suppositories, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). SSP 032 – Lipitor® 10mg chewable tablets Effective today, 31 May 2022, SSP032 provides that for every Lipitor® 10mg chewable tablet
Read moreThe Department of Health and Social Care (DHSC) has updated Annex A of SSP022 and SSP023 for Oestrogel® Pump-Pack 0.06% gel to include a dose conversion to a specific alternative Estradiol patch for patients who use 1 pump of Oestrogel® daily. Previously, only dose conversions for patients using 2 to 4 pumps daily were included in Annex A of SSP022
Read more10,797 pharmacy contractors who declared their April 2022 FP34C submission figures through the Manage Your Service (MYS) portal by 6 May 2022 received their earlier advance payments on Thursday 12 May 2022 (circa 20 days earlier than the normal advance payment timetable). This leaves c.400 contractors who did not receive any earlier advance payments in
Read more
The NHS Business Services Authority (NHSBSA) report seeing a rise in items that are being referred back (RB) to contractors for the reason code RB2B: ‘The order/endorsement is incomplete. The presentation must be present.’ The NHSBSA note that this issue is most commonly seen with handwritten prescriptions. Where prescription does not specify the presentation of a drug
Read moreThe NHS prescription charge is reviewed annually with changes usually made in April, however, this year the Government has yet to conclude consideration of any future increases to prescription charges. Following our announcement that the NHS prescription charge would not be uplifted on 1 April 2022, a decision is yet to be reached on any
Read more
The Review Steering Group (RSG) has published its proposals for the future of community pharmacy contractor representation and support. The proposals make 37 recommendations for the future of PSNC and the LPCs which the RSG says have been written to: Strengthen governance; Better align with the NHS; Appropriately resource representatives; and Strengthen collaboration. The RSG
Read more
